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De novo glomerular osteopontin expression in rat crescentic glomeru-
lonephritis. Osteopontin (OPN) is a secreted acidic glycoprotein that has
potent monocyte chemoattractant and adhesive properties. Up-regulation
of tubular OPN expression is thought to promote interstitial macrophage
infiltration in experimental nephritis; however, the role of OPN in
glomerular lesions, particularly crescent formation, is unknown. The
present study used Northern blotting, in situ hybridization and immuno-
histochemistry to examine OPN expression in a rat model of accelerated
anti-GBM glomerulonephritis. Osteopontin mRNA and protein is ex-
pressed by some parietal epithelial cells, thick ascending limbs of Henle
and medullary tubules and collecting ducts in normal rat kidney. De novo
OPN mRNA and protein expression was evident in glomerular visceral
and parietal epithelial cells in anti-GBM glomerulonephritis. Glomerular
OPN expression preceded and correlated with macrophage infiltration in
the development of hypercellularity, focal and segmental lesions and,
notably, crescent formation. There was marked up-regulation of OPN
expression by tubular epithelial cells that also preceded and correlated
with interstitial macrophage (r 5 0.93, P , 0.001) and T-cell infiltration
(r 5 0.85, P , 0.001). Both glomerular and tubular OPN expression
correlated significantly with proteinuria (P , 0.001) and a reduction in
creatinine clearance (P , 0.01). In addition, double immunohistochemis-
try showed co-expression of osteopontin and one of its ligands, CD44, in
intrinsic renal cells. CD44 and OPN expression by parietal epithelial cells
was evident in crescent formation, while virtually all OPN-positive tubules
expressed CD44. Infiltrating macrophages and T-cells were CD44-posi-
tive, but only a small proportion of T-cells and few macrophages showed
OPN expression. Interestingly, strong OPN mRNA and protein expression
was seen in macrophage multinucleated giant cells. In summary, this study
suggests that OPN promotes macrophage and T-cell infiltration in the
development of renal lesions in rat anti-GBM glomerulonephritis, includ-
ing glomerular crescent and multinucleated giant cell formation.
Osteopontin (OPN) is a highly acidic, phosphorylated, secreted
glycoprotein which contains an adhesive arginine-glycine-aspartic
acid (RGD) sequence [1, 2]. Osteopontin is expressed in a
constitutive or inducible fashion by a number of cell types,
including: osteoclasts, various epithelia, macrophages, T lympho-
cytes, smooth muscle cells and some tumors [3–8]. A number of
different forms of OPN have been described in various cell types
that result from alternative RNA splicing and post-translational
modifications such as glycosylation, phosphorylation and proteo-
lytic cleavage [1, 2]. Osteopontin is a cell adhesion and migration
molecule and functions through binding to a number of ligands
including the avb3 integrin (vitronectin receptor), extracellular
matrix proteins such as collagen type I and fibronectin, and CD44
[1, 2, 9]. The adhesive properties of OPN have been implicated in
a diverse array of biological responses such as bone absorption,
inhibition of renal stone formation, tumor metastasis and macro-
phage recruitment at sites of inflammation [8, 10–13]. Further-
more, OPN and its proteolytic fragments have been shown to have
potent chemotactic activity [14, 15]. Indeed, the subcutaneous
injection of OPN into mice induces prominent monocyte infiltra-
tion [13].
Macrophage infiltration plays an important role in the patho-
genesis of many types of kidney disease [16]. Much interest has,
therefore, been focused on the mechanisms by which macro-
phages are recruited into the kidney and interact with intrinsic
kidney cell types. Examination of experimental models of glomer-
ular and interstitial nephritis have found that the development of
interstitial macrophage infiltration is almost exclusively restricted
to areas of tubular damage in which there is marked up-regulation
of tubular OPN mRNA and protein expression [17–22]. However,
the potential importance of OPN in the pathogenesis of macroph-
age-mediated glomerular lesions, such as crescent formation, and
the relationship between OPN and CD44 expression in glomeru-
lonephritis have not been addressed. Therefore, we studied a rat
model of crescentic glomerulonephritis in order to determine (1)
whether OPN contributes to the development of glomerular
lesions, and (2) the relationship between expression of OPN and
one of its ligands, CD44, in disease development.
METHODS
Experimental disease model
Accelerated anti-GBM glomerulonephritis was induced in in-
bred male Sprague-Dawley rats (150 to 200 g) as previously
described [23]. Briefly, animals were immunized s.c. with 5 mg
normal rabbit IgG in Freund’s complete adjuvant and injected i.v.
with 10 ml/kg rabbit anti-rat GBM serum (12.5 mg IgG/ml) five
days later (termed day 0). Groups of 6 rats were killed at three
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hours, and days 1, 7, 14 or 21 after administration of nephrotoxic
serum. In addition, a group of 6 normal rats was studied.
Histopathology
Tissues for histology were fixed in 4% formalin and 4 mm
paraffin sections were stained with hematoxylin and eosin (H&E)
or periodic acid-Schiff reagent (PAS). The percentage of glomer-
uli exhibiting atrophy/segmental sclerosis, global sclerosis or glo-
merular crescentic formation was assessed by examination of at
least 100 glomerular cross sections (gcs) per animal in PAS-
stained sections. Glomerular hypercellularity was assessed on the
basis of total glomerular cell counts per glomerular cross-section.
At least 100 glomeruli per animal were scored on H&E stained
sections and ranked as follows: (0) normal (less than 50 cells/gcs);
(1) mild (60 to 80 cells/gcs); (2) moderate (80 to 120 cells/gcs); (3)
severe hypercellularity (more than 120 cells/gcs). Cortical tubular
atrophy and fibrosis were semiquantitatively analyzed on PAS
stained sections and graded on a scale of 0 to 3 as follows: (0) no
apparent damage; (1) mild damage, with lesions involving less
than 15% of the cortex; (2) moderate damage, involving 15% to
30% of the cortex; (3) severe damage, that is, involving more than
30% of the cortex and focal accumulation of leukocytes at sites of
damage.
Renal function and proteinuria
Urinary protein excretion in 24 hour collections was deter-
mined using the Manual Ponceau Red method. Concentrations of
plasma and urine creatinine were measured using the standard
Jaffe rate reaction (alkaline picrate). All analyses were performed
by the Department of Biochemistry, Monash Medical Centre.
Antibodies
Mouse monoclonal antibodies (mAb) used were: MPIIIB10,
anti-rat OPN (obtained from the Developmental Studies Hybrid-
oma Bank, Iowa City, IA, USA); ED1, anti-rat CD68, labels
monocytes and macrophages [24, 25]; R73, anti-rat ab T-cell
receptor non-polymorphic determinant [26]; OX-50, anti-rat
CD44 which recognizes all forms of CD44 [27, 28]. Peroxidase-
and alkaline phosphatase-conjugated goat anti-mouse IgG, mouse
peroxidase anti-peroxidase complexes (PAP), and mouse alkaline
phosphatase anti-alkaline phosphatase complexes (APAAP) were
purchased from Dakopatts (Glostrup, Denmark).
Immunohistochemistry
Double immunostaining was performed on 4 mm paraffin
sections of formalin-fixed kidney using a microwave-based
method of multiple immunoenzymatic staining, which has been
described in detail elsewhere [29]. Briefly, sections were dewaxed,
placed in 0.01 M sodium citrate buffer pH 6.0 and heated for 2 3
5 minutes in a microwave oven at 2450 MHz and a power output
of 800 watts. This facilitates retrieval of cytoplasmic antigens.
Sections then were labeled with the ED1 mAb using a 3 layer PAP
method and developed with 3,3-diaminobenzidine to give a brown
product. Sections then were microwave heated a second time to
denature bound IgG molecules on the section, inactivate endog-
enous alkaline phosphatase and prevent antibody cross-reaction
[29]. Sections were labeled with the MPIIIB10 mAb using a 3
layer APAAP method and developed with Fast Blue BB Base
(Sigma Chemical Co., St. Louis, MO, USA), giving a blue product.
Double immunostaining was also performed on cryostat sec-
tions of tissue fixed in 2% paraformaldehyde-lysine-periodate. In
this case, sections were labeled with OX-50 or R73 mAb with a 3
layer PAP method before the sections were microwave treated,
and then stained with ED1 or MPIIIB10 mAb and developed with
a 3 layer APAAP method.
All sections were counterstained with periodic acid-Schiff
(PAS) reagent without hematoxylin and coverslipped in an aque-
ous mounting medium. An isotype-matched mouse antibody 73.5
against human CD45R was used as the negative control.
Probes
A 1 kb cRNA probe was generated from the 2B7 cDNA clone
of rat smooth muscle osteopontin [7]. Sense and anti-sense cRNA
probes were labeled with digoxigenin (DIG)-UTP using a T7
RNA polymerase kit (Boehringer Mannheim GmbH, Mannheim,
Germany). In addition, a 358 bp fragment of rat glyceraldehyde-
3-phosphate dehydrogenase (GAPDH) cDNA was amplified by
reverse transcription PCR and labeled with DIG-dUTP using the
High-Prime random priming kit (Boehringer Mannheim GmbH).
Probes were precipitated and incorporation of DIG was deter-
mined by dot blotting.
Northern blot analysis
Northern blotting was performed as previously described [30].
Briefly, total cellular RNA was extracted using the RNAzol
reagent (Gibco BRL, Gaithersburg, MD, USA), and 20 mg
samples were denatured with glyoxal and dimethylsulphoxide, size
fractionated on 1.2% agarose gels and capillary blotted onto
positively-charged nylon membranes (Boehringer Mannheim).
Membranes were hybridized overnight at 68°C or 42°C with
DIG-labeled cRNA or cDNA probes, respectively, in a DIG Easy
Hyb solution (Boehringer Mannheim). Following hybridization,
membranes were washed finally in 0.1 3 SSC/0.1% SDS at 68°C
or 0.2 3 SSC/0.1% SDS at 42°C. Bound probes were detected
using sheep anti-DIG antibody (Fab) conjugated with alkaline
phosphatase and development with CPD-star enhanced chemilu-
minescence (Boehringer Mannheim). Chemiluminescence emis-
sions were captured on Kodak XAR film and densitometry
analysis performed using the public domain NIH ImagePC pro-
gram (developed at the U.S. National Institutes of Health and
available on the Internet at http://rsb.info.nih.gov/nih-image/).
In situ hybridization
In situ hybridization was performed on 4 mm paraffin sections of
formalin-fixed tissue using a microwave-based protocol as de-
scribed in detail elsewhere [31, 32]. After dewaxing, sections were
treated with a microwave oven for 2 3 five minutes as described
above, incubated with 0.2 M HCl for 15 minutes, followed by 1%
Triton X-100 for 15 minutes, and then digested for 20 minutes
with 10 mg/ml Proteinase-K at 37°C (Boehringer Mannheim).
Sections then were washed in 2 3 SSC, prehybridized, and then
hybridized with 0.3 ng/ml DIG-labeled sense or anti-sense OPN
cRNA probe overnight at 37°C in a hybridization buffer contain-
ing 50% deionized formamide, 4 3 SSC, 2 3 Denhardt’s solution,
1 mg/ml salmon sperm DNA, and 1 mg/ml yeast tRNA. Sections
were washed finally in 0.1 3 SSC at 37°C and the hybridized probe
detected using sheep anti-DIG antibody (Fab) conjugated with
alkaline phosphatase and color development with NBT/X-phos-
phate (Boehringer Mannheim). Sections were mounted in an
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aqueous medium. No signal was seen with the sense riboprobe
labeled to the same specific activity.
Quantitation of in situ hybridization and
immunohistochemistry staining
Positively stained cells were quantitated in tissue sections as
previously described [32, 33]. Briefly, the number of cells labeled
with the OPN cRNA probe or the different mAb were counted in
at least 50 glomeruli cross-sections per animal. Interstitial ED11
macrophages and R731 T-cells were counted in at least 20
consecutive high power fields moving from outer cortex to inner
cortex by means of a 0.02 mm2 graticule fitted in the eyepiece of
microscope. The number of tubules positive for OPN, CD44 or
both molecules (CD441OPN1) were scored from at least 1000
cortical tubules. In addition, a point counting technique was used
to quantitate the number of interstitial ED11 or R731 cells
surrounding OPN1 and OPN-tubules. Finally, OPN1 and OPN-
cortical tubules were assessed for tubulitis by scoring the presence
of OX-11 leukocytes between and/or within the tubules in at least
1000 cortical tubules per animal. Data are expressed as the
mean 6 SEM for groups of six animals.
Statistical analyses
One way analysis of variance (ANOVA) from the Complete
Statistical Analysis program (CSS, Statsoft, USA) was used to
analyze differences in clinical data and quantitative immunohis-
tochemistry scoring. The Pearson single correlation coefficient
was used to compare OPN protein expression with macrophage
and T cell accumulation, proteinuria and renal impairment. The
relationship between OPN expression and glomerular and tubu-
lointerstitial damage was compared using the Spearman’s rank
correlation coefficient.
RESULTS
Osteopontin expression in normal rat kidney
Northern blotting demonstrated constitutive expression of a
single 1.6 kb species of OPN mRNA in normal rat kidney (Fig.
1A). In situ hybridization and antibody staining identified weak
OPN mRNA and protein expression by occasional glomerular
parietal epithelial cells and rare cells within the glomerular tuft
(Figs. 2A, 3A, and 4A). In the tubulointerstitium, OPN mRNA
and protein expression was largely restricted to the thick ascend-
ing limbs of the loop of Henle, accounting for less then 5% (3.3 6
1.8%) of all cortical tubules (Figs. 2A, 3A, and 5A), whereas most
medullary tubules exhibited weak OPN mRNA and protein
expression. No staining was seen using the OPN sense control
probe (not shown).
Up-regulation of osteopontin gene expression in anti-GBM
disease
Northern blot analysis of whole kidney RNA demonstrated a
4.6-fold increase in OPN mRNA levels relative to GAPDH
mRNA on day 1 of anti-GBM disease, and OPN mRNA levels
continued to increase over the disease course (Fig. 1).
De novo glomerular OPN expression, leukocyte accumulation
and crescent formation
Severe glomerular lesions developed over the 21 day course of
rat anti-GBM glomerulonephritis, including: hypercellularity, seg-
mental lesions and crescent formation (Table 1). In situ hybrid-
ization and immunostaining showed a significant increase in the
number of OPN1 glomerular cells during the progression of the
disease (Fig. 4A). Glomerular OPN expression was evident within
focal and global lesions, with OPN1 cells identified as predomi-
nantly visceral epithelial cells, although a small number of ED11
macrophages also showed OPN expression (Figs. 2B and 3B). An
important observation was the de novo OPN expression by
parietal epithelial cells on day 1 of disease, which became more
prominent as the disease progressed over days 7 to 21. This de
novo OPN expression was demonstrated by both in situ hybridiza-
tion and immunohistochemistry (Figs. 2 B-E and 3C), and pre-
ceded the accumulation of ED11 macrophages within Bowman’s
space beginning on day 7 of the disease. Examination of individual
glomeruli found a clear association between increased OPN
expression by parietal epithelial cells and ED11 macrophage
Fig. 1. Northern blot analysis of osteopontin (OPN) mRNA in normal
and diseased rat kidney. (A) Detection of a single 1.6 kb OPN mRNA
species in normal kidney and on days 1 to 21 of anti-GBM disease. Blots
were reprobed for GAPDH. (B) Graph of the normalized OPN to
GAPDH mRNA ratio.
Table 1. Histopathology in rat anti-GBM glomerulonephritis
Day of
Disease
Glomerular
hypercellularity
(0–3)
Glom.
segmental
lesions %
Glomerular
crescents %
Tubulointerstitial
lesions %
Day 1 0.7 6 0.1 12 6 3.2 0 4.3 6 0.5
Day 7 2.1 6 0.2 25 6 4.5 13.5 6 1.1 12.5 6 2.2
Day 14 2.5 6 0.2 33 6 3.5 32.6 6 4.5 22.6 6 2.8
Day 21 2.8 6 0.3 46 6 3.8 48.8 6 5.1 38.5 6 3.6
Data were obtained from groups of 6 animals (mean 6 SEM).
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Fig. 2. Detection of osteopontin (OPN) mRNA by in situ hybridization in rat anti-GBM glomerulonephritis. (A) Normal rat kidney showing weak OPN
mRNA expression by glomerular parietal epithelial cells (arrowheads) and thick ascending limbs of Henle (asterisks). (B) Increased OPN mRNA
expression by glomerular parietal epithelial cells, podocytes (arrowhead) and some proximal tubules on day 1 of disease. (C) Day 7 showing strong
up-regulation of OPN mRNA expression by glomerular parietal epithelial cells and proximal and distal tubules. (D) Day 14 showing marked OPN
mRNA expression in a glomerular crescent (c). (E) Day 21 showing strong OPN mRNA expression by glomerular visceral epithelial cells (arrowheads)
and atrophic tubules and spindle-shaped fibroblast-like cells (arrows) in an area of tubulointerstitial damage. (F) Day 21 showing OPN mRNA
expression by a multinucleated giant cell (*) within a glomerular lesion. G, glomerulus. Original magnification 3250 (A-E) and 3400 (F).
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Fig. 4. Quantitation of glomerular osteopontin (OPN) and CD44 expres-
sion and leukocyte infiltration in rat anti-GBM glomerulonephritis. (A)
Cells positive for OPN mRNA (F) or OPN protein (E); (B) glomerular
CD441 cells (F) and OPN1CD441 double-positive cells (E); (C)
glomerular ED11 macrophages (F) and R731 T-cells (E). Data are
expressed as the mean 6 SEM from groups of 6 animals per glomerular
cross-section (gcs). *P , 0.05, **P , 0.01, ***P , 0.001 compared to
normal animals (day 0).
Fig. 5. Quantitation of tubular osteopontin (OPN) and CD44 expression
and interstitial macrophage and T-cell accumulation in rat anti-GBM
glomerulonephritis. (A) Tubules positive for OPN mRNA (F) and OPN
protein (E); (B) CD441 tubules (F) and OPN1CD441 double-positive
tubules (E); (C) interstitial ED11 macrophages (F) and R731 T-cells
(E). Data are expressed as the mean 6 SEM from groups of 6 animals.
**P , 0.01, ***P , 0.001 compared to normal animals (day 0).
Fig. 3. Double immunohistochemistry staining of osteopontin (OPN) protein in normal kidney and rat crescentic glomerulonephritis. (A) Normal rat
kidney showing co-localization of OPN (blue) and CD44 (brown) protein in thick ascending limbs of the loop of Henle (arrowhead). Some distal tubules
show only CD44 expression. (B) Focal up-regulation of glomerular OPN protein expression (blue) and ED11 macrophage accumulation (brown) in a
focal segmental glomerular lesion. Note that some ED11 macrophages are also OPN-positive. (C) Up-regulation of OPN expression by glomerular
parietal epithelial cells (blue) and ED11 macrophage accumulation (brown) in glomerular crescent formation. Some ED11 macrophages are also
OPN-positive. (D) Strong OPN expression by an ED11 macrophage multinucleated giant cell (white arrow) within a granulomatous lesion on day 21
of disease. Note also strong OPN expression by tubules and in areas of tubulitis (*). (E) R731 T-cells (brown) were localized within an area of tubulitis
(*) exhibiting strong tubular OPN expression (blue). (F) Co-localization of OPN (blue) and CD44 (brown) within a glomerular crescent and an area
of tubulointerstitial damage. Sections were counterstained with PAS minus hematoxylin. Original magnification 3400.
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accumulation within Bowman’s space, contributing to crescent
formation (Fig. 3C). In addition, some spindle-shaped fibroblast-
like cells in fibrocellular crescents showed OPN expression.
Quantitation of glomerular OPN1 cells, macrophages and T-cells
over the entire disease course found a highly significant correla-
tion between glomerular OPN expression and macrophage accu-
mulation, and also a significant correlation between glomerular
OPN expression and T-cell accumulation (Fig. 6 A, B).
An interesting observation was the strong OPN mRNA and
protein expression seen in ED11 macrophage multinucleated
giant cells (MGC), which were present within granulomatous-like
lesions (Figs. 2F and 3D). Osteopontin1 MGC were seen in both
glomerular and interstitial lesions.
Up-regulation of tubular osteopontin expression, leukocyte
accumulation and tubulointerstitial injury
Up-regulation of tubular OPN mRNA and protein expression
was evident as early as three hours following administration of
anti-GBM serum, and this continued to increase over the disease
course (Fig. 5A). The up-regulation of tubular OPN expression
preceded the development of significant macrophage infiltration
on day 1, and paralleled macrophage accumulation over the rest
of the disease course (Fig. 5). This early de novo OPN expression
was seen in proximal tubules adjacent to the glomerular hilar area
(Fig. 2B) and in tubules adjacent to glomeruli and arterioles. By
day 7 there was a patchy, focal pattern of tubular OPN expression,
with OPN expression seen in 55 to 85% of cortical tubules over
days 14 to 21 (Fig. 5A).
In situ hybridization and double immunohistochemistry staining
showed that the marked up-regulation of tubular OPN mRNA
and protein expression occurred in areas of focal tubulointerstitial
macrophage and T cell infiltration, tubulitis, tubular atrophy and
tubulointerstitial fibrosis (Figs. 2E and 3E). There was a highly
significant correlation between the number of OPN1 tubules and
macrophage and T-cell accumulation within the cortical intersti-
tial compartment (Fig. 6 C, D). Furthermore, quantitative analysis
demonstrated that most infiltrating peritubular macrophages and
T cells accumulated around OPN1 tubules (Fig. 7 A, B), and that
the incidence of tubulitis was much greater in OPN1 tubules as
compared to OPN-tubules (Fig. 7C). In contrast, there was little
change in the constitutive OPN mRNA and protein expression in
medullary tubules over the 21 day disease course.
Fig. 6. Correlation analysis of leukocyte accumulation and osteopontin (OPN) expression over the 21 day time course of rat anti-GBM
glomerulonephritis. (A) Glomerular ED11 macrophages and OPN1 cells (r 5 0.946; P , 0.001); (B) glomerular R731 T-cells and OPN1 cells (r 5
0.451; P , 0.05); (C) interstitial ED11 macrophages and the percentage of OPN1 tubules (r 5 0.933; P , 0.001); (D) interstitial R731 T-cells and
the percentage of OPN1 tubules (r 5 0.857; P , 0.001). The Pearson correlation coefficient is shown.
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Correlation of osteopontin expression with progressive renal
injury
The number of OPN1 glomerular cells, parietal epithelial cells
and cortical tubules was compared with histopathology and clin-
ical disease parameters over the 21 day time course of anti-GBM
glomerulonephritis. As shown in Table 2, the number of OPN1
cells in the glomerular tuft gave a significant correlation with
glomerular hypercellularity, segmental lesions, proteinuria and
loss of renal function. The number of OPN1 parietal epithelial
cells correlated significantly with glomerular crescent formation,
while the number of OPN1 cortical tubules correlated signifi-
cantly with tubulointerstitial lesions, proteinuria and the loss of
renal function.
Co-localization of osteopontin and CD44 expression
The relationship between expression of OPN and one of its
ligands, CD44, was examined by double immunohistochemistry.
Consistent with a previous study [33], immunostaining with the
OX-50 mAb identified constitutive CD44 expression by parietal
epithelial cells, occasional glomerular cells, medullary tubules and
some thick ascending limbs of Henle in normal rat kidney. Most
cortical and medullary CD441 tubules also expressed OPN (Fig.
3A).
In anti-GBM disease, there was a rapid increase in the number
of glomerular CD441 cells at three hours after injection of
anti-GBM serum (Fig. 4A). This was due to CD44 expression by
the early, transient glomerular neutrophil infiltrate (not shown).
From day 1 onwards, glomerular CD44 expression was due to
infiltrating macrophages and resident glomerular visceral and
parietal epithelial cells. In crescent formation, parietal epithelial
cells expressed both CD44 and OPN, while macrophages within
Bowman’s space were mostly of a CD441OPN-phenotype, as
shown in Figure 3F.
There was also a marked increase in CD44 expression by
cortical tubules in areas of tissue damage that paralleled the
increase seen in tubular OPN expression, except during the first
24 hours in there was a more rapid up-regulation of tubular OPN
expression compared to that of CD44 (Fig. 5B). Double staining
showed that most OPN1 tubules also expressed CD44 (Fig. 3F).
Interestingly, CD44 was expressed more strongly on the basolat-
eral surface and tight junctions than on the luminal surface,
whereas OPN was more prominent on the luminal surface and
within the cytoplasm compared to the basolateral surface. CD44
was also expressed by most infiltrating interstitial leukocytes and
by some spindle-shaped fibroblast-like cells.
DISCUSSION
In accord with previous studies, we have demonstrated consti-
tutive OPN mRNA and protein expression in normal rat kidney
[4, 18]. Although the function of OPN in normal kidney is not
known, it has been proposed that OPN plays a role in preventing
stone formation based upon the ability of OPN to inhibit calcium
oxalate crystal formation in vitro [12].
A close association between the up-regulation of cortical tubu-
lar OPN expression and interstitial macrophage infiltration has
been observed in a number of models of glomerular and intersti-
tial nephritis [17–22]. Such an association was also demonstrated
in the current study of rat anti-GBM glomerulonephritis, in which
up-regulation of cortical tubular OPN expression preceded inter-
stitial macrophage infiltration. Indeed, not only was there a highly
significant correlation between up-regulation of tubular OPN
expression and interstitial macrophage infiltration, but a signifi-
cant correlation between interstitial T-cell infiltration and tubular
OPN expression was also seen.
In renal disease models, most attention has focused upon the
up-regulation of OPN expression by cortical tubules, but little is
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Fig. 7. Quantitation of tubular osteopontin (OPN) expression, intersti-
tial macrophage and T-cell accumulation, and tubulitis in rat anti-GBM
glomerulonephritis. (A) Peritubular accumulation of ED11 macrophages
around OPN1 tubules (f) and OPN-tubules (M). (B) Peritubular accu-
mulation of R731 T-cells around OPN1 tubules (f) and OPN-tubules
(M). (C) The percentage of OPN1 tubules (f) and OPN-tubules (M)
exhibiting tubulitis. Data are expressed as the mean 6 SEM from groups of
6 animals. *P , 0.05, **P , 0.001.
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known of the potential role of OPN in the development of
glomerular lesions. Weak OPN expression is evident by some
parietal epithelial cells in normal kidney and an increase in OPN
expression by the epithelial cells of Bowman’s capsule has been
noted in unilateral ureter obstruction and in glomerular under-
going sclerosis in aging mice [4, 20]. In addition, glomerular OPN
mRNA expression has been reported in rat mesangioproliferative
anti-Thy-1 nephritis at the time of glomerular macrophage accu-
mulation, although this association was not examined in detail
[18]. The current study has demonstrated marked up-regulation of
OPN expression in severe glomerular lesions, suggesting that
OPN contributes to the development of macrophage-induced
segmental lesions, including crescent formation. Areas of focal
glomerular macrophage accumulation were associated with focal
OPN expression by predominantly visceral epithelial cells. It was
notable that up-regulation of OPN expression by parietal epithe-
lial cells occurred prior to macrophage accumulation within
Bowman’s space. Therefore, parietal epithelial cells may promote
macrophage accumulation within Bowman’s space either through
the chemotactic activity of secreted OPN or the potent macroph-
age-adhesive property of cell-surface OPN [6, 13]. In addition,
OPN expression by fibroblast-like cells suggest a role for OPN in
the progression of crescents from a cellular to a fibrocellular
phenotype.
One interesting observation was the strong OPN expression by
macrophage MGC, while most infiltrating mononuclear macro-
phages had no detectable OPN expression. Given the potent
adhesive properties of OPN for macrophages [6, 13], the expres-
sion of OPN on the surface of macrophages may promote cell-cell
fusion during the formation of MGC. Indeed, examination of
osteoclast formation supports this postulate. A study of osteo-
phytic bone and inflammatory connective tissues found that
mononuclear macrophages gained OPN mRNA expression when
they changed from a non-specific esterase-positive phenotype to a
tartrate-resistant acid phosphatase-positive phenotype during the
formation of osteoclast MGC [34]. In addition, retinoic acid,
which induces osteoclast formation, also up-regulates OPN
mRNA in bone marrow-derived osteoclast precursors [35].
One ligand for OPN is CD44, a molecule which is expressed by
infiltrating macrophages and T-cells and markedly up-regulated
by intrinsic renal cells in the development of rat crescentic
glomerulonephritis [33]. In the current study, examination of the
relationship between OPN and CD44 expression provided two
interesting results. First, a CD44-OPN interaction may promote
leukocyte adhesion in the development of both tubulointerstitial
and glomerular lesions, based upon the co-localization of CD441
macrophages and T-cells with OPN1 tubular and glomerular
epithelial cells. In addition, fibroblast migration into Bowman’s
space during the development of fibrocellular crescents may
involve a CD44-OPN interaction. Second, an unexpected finding
was that almost all glomerular and interstitial epithelial cells that
expressed OPN also expressed CD44. This was evident in medul-
lary tubules and collecting ducts in normal kidney, and in cortical
tubules and glomerular parietal and visceral epithelial cells in
areas of tissue damage in crescentic glomerulonephritis. These
molecules may have distinct functional roles in the tubular
response to injury, with OPN promoting recruitment and adhe-
sion of macrophages and T-cells, whereas CD44 may promote
epithelial cell adhesion to hyaluronan within the tubular basement
membrane and facilitate epithelial cell-cell adhesion at tight
junctions through a CD44-CD44 interaction mediated by a hy-
aluronan bridge, similar to that previously described for fibro-
blasts and mesangial cells [36, 37].
In summary, this study has identified a potential pathogenic role
for OPN in macrophage and T-cell infiltration in the development of
renal lesions in rat anti-GBM glomerulonephritis, including the
formation of glomerular crescents and multinucleated giant cells. In
vivo blocking studies are now required to provide functional evidence
of the importance of OPN in the development of glomerular and
tubulointerstitial damage in renal injury.
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APPENDIX
Abbreviations used in this article are: OPN, osteopontin; GBM, glo-
merular basement membrane; CD44, ligand to osteopontin; RGD, argin-
ine-glycine-aspartic acid; PAS, Periodic acid-Schiff reagent; mAb, mono-
clonal antibodies; PAP, peroxidase anti-peroxidase complexes; APAAP,
alkaline phosphatase anti-allkaline phosphatase complexes; DIG, digoxi-
genin; GAPDH, glyceraldehyde-3-phosphate dehydrogenase; MCG,
multinucleated giant cells.
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